di Tomaso; Emmanuelle

Patent Applications and Registrations

Patent applications and USPTO patent grants for di Tomaso; Emmanuelle.The latest application filed is for "dosage regimen for an alpha-isoform selective phosphatidylinositol 3-kinase inhibitor".

Company Profile

4.4.16

di Tomaso; Emmanuelle - Lexington MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Dosage Regimen For An Alpha-isoform Selective Phosphatidylinositol 3-kinase Inhibitor App 20210196696 - di Tomaso; Emmanuelle ; et al.	2021-07-01
Treatment Of Cancer With A Pi3k Inhibitor In A Patient Preselected For Having A Pik3ca Mutation In The Ctdna App 20200138824 - di Tomaso; Emmanuelle	2020-05-07
Compositions And Methods For Treating Cancers With Covalent Inhibitors Of Cyclin-dependent Kinase 7 (cdk7) App 20200113902 - Rajagopal; Nisha ; et al.	2020-04-16
Dosage Regimen For An Alpha-isoform Selective Phosphatidylinositol 3-kinase Inhibitor App 20200069670 - di Tomaso; Emmanuelle ; et al.	2020-03-05
Dosage regimen for an alpha-isoform selective phosphatidylinositol 3-kinase inhibitor Grant 10,434,092 - di Tomaso , et al. O	2019-10-08
Treatment Of Cancer With A Pi3k Inhibitor In A Patient Presselected For Having A Pik3ca Mutation In The Ctdna App 20180353515 - di Tomaso; Emmanuelle	2018-12-13
Dosage Regimen For A Phosphatidylinositol 3-kinase Inhibitor App 20180280370 - Schnell; Christian ; et al.	2018-10-04
Dosage Regimen For An Alpha-isoform Selective Phosphatidylinositol 3-kinase Inhibitor App 20180078540 - di Tomaso; Emmanuelle ; et al.	2018-03-22
Combination of a PI3 kinase inhibitor with pacitaxel for use in the treatment or prevention of a cancer of the head and neck Grant 9,913,846 - Hirawat , et al. March 13, 2	2018-03-13
Combination of a PI3 Kinase Inhibitor with Pacitaxel for Use in the Treatment or Prevention of a Cancer of the Head and Neck App 20170173032 - Hirawat; Samit ; et al.	2017-06-22
Synergistic combinations of PI3K- and MEK-inhibitors Grant 9,675,595 - Fritsch , et al. June 13, 2	2017-06-13
Dosage Regimen For An Alpha-isoform Selective Phosphatidylinositol 3-kinase Inhibitor App 20170000778 - di Tomaso; Emmanuelle ; et al.	2017-01-05
Pharmaceutical Combinations App 20160129003 - Hirawat; Samit ; et al.	2016-05-12
Combination of a PI3 Kinase Inhibitor with Pacitaxel for Use in the Treatment or Prevention of a Cancer of the Head and Neck App 20160082012 - Hirawat; Samit ; et al.	2016-03-24
Synergistic Combinations Of Pi3k- And Mek-inhibitors App 20140179744 - Christine; Fritsch ; et al.	2014-06-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.